Brett Delahunt

Author PubWeight™ 100.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013 3.68
2 Prostate cancer screening--finding the middle road forward. N Z Med J 2005 3.38
3 The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol 2016 2.94
4 Revised status of PSA testing in the early detection and treatment of prostate cancer. N Z Med J 2011 2.54
5 Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. Lancet Oncol 2012 2.19
6 Uncommon and recently described renal carcinomas. Mod Pathol 2009 2.13
7 Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases. Histopathology 2013 2.00
8 Prostate specific antigen testing: age-related interpretation in early prostate cancer detection. Pathology 2013 1.98
9 Vasectomy and risk of prostate cancer. JAMA 2002 1.75
10 Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res 2005 1.63
11 Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 2002 1.54
12 Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology 2013 1.53
13 Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension. Hum Pathol 2009 1.51
14 Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol 2006 1.50
15 Redox status of acute pancreatitis as measured by cyclic voltammetry: initial rodent studies to assess disease severity. Crit Care Med 2008 1.39
16 Recently described and unusual variants of urothelial carcinoma of the urinary bladder. Pathology 2012 1.29
17 Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol 2006 1.22
18 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 2010 1.22
19 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 2010 1.22
20 The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation. Arch Pathol Lab Med 2014 1.17
21 Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol 2013 1.17
22 Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 2010 1.16
23 Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol 2013 1.15
24 Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens. Pathology 2011 1.14
25 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 2010 1.12
26 Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol 2007 1.12
27 Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006 1.11
28 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol 2010 1.09
29 Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. Am J Surg Pathol 2014 1.08
30 Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol 2009 1.07
31 The lung is an important site for priming CD4 T-cell-mediated protective immunity against gastrointestinal helminth parasites. Infect Immun 2010 1.07
32 Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis. Mod Pathol 2002 1.07
33 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol 2010 1.07
34 Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn 2002 1.04
35 Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 2005 1.03
36 Parameters of perineural invasion in radical prostatectomy specimens lack prognostic significance. Mod Pathol 2008 1.02
37 A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial. Int J Radiat Oncol Biol Phys 2010 0.97
38 Changes in the mesenteric lymph proteome induced by hemorrhagic shock. Shock 2010 0.97
39 Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles. Am J Surg Pathol 2010 0.97
40 Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis. Eur J Immunol 2008 0.97
41 Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives. Anticancer Res 2004 0.95
42 Allergen-specific CTL require perforin expression to suppress allergic airway inflammation. J Immunol 2012 0.93
43 Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma: a unifying concept. Anticancer Res 2010 0.91
44 Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 2006 0.90
45 The proteome of mesenteric lymph during acute pancreatitis and implications for treatment. JOP 2009 0.90
46 Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014 0.87
47 Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med 2010 0.87
48 Chromosome 14q LOH in localized clear cell renal cell carcinoma. J Pathol 2002 0.86
49 The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer. Pathology 2015 0.85
50 International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens: rationale and organization. Mod Pathol 2010 0.85
51 Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice. Tuberculosis (Edinb) 2012 0.84
52 Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer. Radiother Oncol 2012 0.84
53 Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology. J Clin Pathol 2011 0.83
54 Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology 2010 0.83
55 Renal dysplasia produced by obstructive uropathy in the fetal lamb. Pathology 2003 0.83
56 Testicular lipomatosis in Cowden's syndrome. Mod Pathol 2005 0.82
57 Prostate cancer--are ethnic minorities disadvantaged? Anticancer Res 2009 0.82
58 Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. Am J Clin Pathol 2010 0.82
59 Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration. Pathology 2010 0.82
60 Biomarkers in renal cancer. Virchows Arch 2014 0.82
61 Warming and humidification have no effect on oxidative stress during pneumoperitoneum in rats. Minim Invasive Ther Allied Technol 2011 0.82
62 High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. J Clin Endocrinol Metab 2002 0.81
63 Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists. Histopathology 2014 0.81
64 Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Virchows Arch 2014 0.81
65 Premalignant lesions of the urinary bladder. Pathology 2013 0.80
66 Prostate cancer: the new evidence base for diagnosis and treatment. Pathology 2007 0.80
67 Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer. BJU Int 2014 0.80
68 Acute pancreatitis severity is exacerbated by intestinal ischemia-reperfusion conditioned mesenteric lymph. Surgery 2007 0.80
69 Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2. Int Immunol 2002 0.80
70 Therapy-associated effects in the prostate gland. Histopathology 2012 0.80
71 Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy. Pathology 2010 0.80
72 Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation. Anticancer Res 2012 0.79
73 Urological pathology comes of age. Pathology 2012 0.79
74 International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens. Adv Anat Pathol 2011 0.79
75 Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. J Clin Endocrinol Metab 2003 0.78
76 A comparison of cancer statistics in New Zealand and Australia: 1996-2007. N Z Med J 2014 0.78
77 Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch 2014 0.78
78 MicroRNAs in mesenteric lymph and plasma during acute pancreatitis. Ann Surg 2014 0.78
79 Premalignancy: the lull before the storm. Pathology 2013 0.78
80 Strongly magnetic iron nanoparticles improve the diagnosis of small tumours in the reticuloendothelial system by magnetic resonance imaging. PLoS One 2013 0.77
81 International Society of Urological Pathology (ISUP) Grading of Prostate Cancer. Am J Surg Pathol 2016 0.77
82 Ductal adenocarcinoma of the prostate: current opinion and controversies. Anal Quant Cytol Histol 2008 0.77
83 Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors. Histol Histopathol 2011 0.77
84 Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases. Am J Surg Pathol 2016 0.77
85 Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases. Am J Surg Pathol 2016 0.77
86 Early organ-specific mitochondrial dysfunction of jejunum and lung found in rats with experimental acute pancreatitis. HPB (Oxford) 2011 0.77
87 Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference. Am J Surg Pathol 2014 0.76
88 Optimising restriction enzyme cleavage of DNA derived from archival histopathological samples: an improved HUMARA assay. Pathology 2003 0.75
89 5-Alpha reductase inhibitors and PSA screening for prostate cancer. Pathology 2014 0.75
90 Re: Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma: T. Klatte, C. Anterasian, J. W. Said, M. de Martino, F. F. Kabbinavar, A. S. Belldegrun and A. J. Pantuck J Urol 2010; 183: 2143-2147. J Urol 2010 0.75
91 Prostate cancer diagnosis: even the experts disagree. Hum Pathol 2006 0.75
92 PSA testing--who should decide when it is performed? N Z Med J 2011 0.75
93 Effective maybe, but is it cost-effective? A reply. Histopathology 2014 0.75
94 Survival benefit confirmed for prostate cancers diagnosed by PSA testing. N Z Med J 2009 0.75
95 The dilemmas of prostate cancer screening. Med J Aust 2013 0.75
96 Screening for prostate cancer: a response to four letters. N Z Med J 2005 0.75
97 FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma. Anticancer Res 2011 0.75
98 Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men. Pathology 2014 0.75
99 Recent advances in urological pathology. Anal Quant Cytopathol Histpathol 2012 0.75
100 Editorial: Genitourinary pathology 120 years on. Pathology 2003 0.75
101 [International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens]. Ann Pathol 2013 0.75
102 Prostate specific antigen testing for the diagnosis of prostate cancer. Pathology 2011 0.75
103 Improving outcomes for New Zealand men with prostate cancer. N Z Med J 2014 0.75
104 Assessment of ethnic variation in serum levels of total, complexed and free prostate specific antigen. Comparison of Maori, Pacific Island and New Zealand European populations. Pathology 2003 0.75
105 Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission. Pathology 2014 0.75
106 The redox status of experimental hemorrhagic shock as measured by cyclic voltammetry. Shock 2010 0.75
107 A further step on the journey. Pathology 2009 0.75
108 Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma. Anal Quant Cytol Histol 2009 0.75
109 Gleason grading: consensus and controversy. Pathology 2009 0.75
110 Myxosarcoma of the right ventricle: an immunohistochemical and ultrastructural study. Anticancer Res 2003 0.75
111 Tertiary Gleason pattern 5 on needle biopsy predicts greater tumour volume on radical prostatectomy. Pathology 2011 0.75
112 Active surveillance guidance for New Zealand men with low-risk prostate cancer. N Z Med J 2015 0.75